Miksiunas, R.; Rucinskas, K.; Janusauskas, V.; Labeit, S.; Bironaite, D.
Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Improves Energetic Status and Cardiomyogenic Differentiation of Human Dilated Myocardium-Derived Primary Mesenchymal Cells. Int. J. Mol. Sci. 2020, 21, 4845.
https://doi.org/10.3390/ijms21144845
AMA Style
Miksiunas R, Rucinskas K, Janusauskas V, Labeit S, Bironaite D.
Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Improves Energetic Status and Cardiomyogenic Differentiation of Human Dilated Myocardium-Derived Primary Mesenchymal Cells. International Journal of Molecular Sciences. 2020; 21(14):4845.
https://doi.org/10.3390/ijms21144845
Chicago/Turabian Style
Miksiunas, Rokas, Kestutis Rucinskas, Vilius Janusauskas, Siegfried Labeit, and Daiva Bironaite.
2020. "Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Improves Energetic Status and Cardiomyogenic Differentiation of Human Dilated Myocardium-Derived Primary Mesenchymal Cells" International Journal of Molecular Sciences 21, no. 14: 4845.
https://doi.org/10.3390/ijms21144845
APA Style
Miksiunas, R., Rucinskas, K., Janusauskas, V., Labeit, S., & Bironaite, D.
(2020). Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Improves Energetic Status and Cardiomyogenic Differentiation of Human Dilated Myocardium-Derived Primary Mesenchymal Cells. International Journal of Molecular Sciences, 21(14), 4845.
https://doi.org/10.3390/ijms21144845